|
|
|
|
Auxilium Pharmaceuticals, Inc. - Financial and Strategic Analysis Review - New Company & Market Analysis
www.companiesandmarkets.com/Summary-Company-Profile/auxilium-pha ..Auxilium Pharmaceuticals, Inc. - Financial and Strategic Analysis Review Summary Auxilium Pharmaceuticals, Inc. (Auxilium) is a specialty biopharmaceutical company...
|
|
|
Auxilium Pharmaceuticals to Present at the Jefferies 3rd Annual Healthcare Conference
-- Auxilium Pharmaceuticals, Inc.(NasdaqGS:AUXL - News) today announced that executive management will participate in the Jefferies 3rd Annual Healthcare Conference to be held June 17 - June 18, 2009 at The Mandarin Hotel in New York City...
|
|
|
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmaceuticals to Present at the Jefferies 3rd Annual Healthcare Con
SOURCE: Auxilium Pharmaceuticals, Inc.MALVERN, PA--(Marketwire - June 5, 2009) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Jefferies 3rd Annual Healthcare Conference...
|
|
|
Auxilium Pharmaceuticals to Present at the Jefferies 3rd Annual
Auxilium Pharmaceuticals, Inc.(NASDAQ: AUXL) today announced that executive management will participate in the Jefferies 3rd Annual Healthcare Conference to be held June 17 - June 18, 2009 at The Mandarin Hotel in New York City. Jim...
|
|
|
Auxilium Pharmaceuticals to Present at the Jefferies 3rd Annual Healthcare Conference
- Auxilium Pharmaceuticals, Inc.(NASDAQ To listen to the audio web cast of the presentation during or after the event, please visit: http://www.auxilium.com. The replay will be available for ninety days after the event. About Auxilium...
|
|
|
Auxilium Pharmaceuticals to Present at the Jefferies 3rd Annual Healthcare Conference
-- Auxilium Pharmaceuticals, Inc.(NasdaqGS:AUXL - News) today announced that executive management will participate in the Jefferies 3rd Annual Healthcare Conference to be held June 17 - June 18, 2009 at The Mandarin Hotel in New York City...
|
|
|
Soleil Securities Initiates Coverage on Auxilium Pharmaceuticals (AUXL) with a Buy; Potential Xiaflex FDA Appr
Soleil Securities initiates coverage on Auxilium Pharmaceuticals (Nasdaq: AUXL) with a Buy.Price target $31. Soleil analyst says, 'Biotech currently marketing Testim, a topical testosterone replacement therapy, for the treatment...
|
|
|
Testosterone side effects prompt FDA's attention to prescription warnings: Healthy Cleveland
Three weeks ago, the Food and Drug Administration announced that it is requiring the manufacturers of two prescription testosterone gel products to include a boxed warning on the products' labels and to provide pharmacies with a medication...
|
|
|
Reproductive Wellness
prompt FDA warnings %%endhead%% I f you ever needed a reason to read those really detailed, re ally long, printed materials that come with your prescription medication (instead of tossing them in the trash), you've got one now.Three weeks...
|
|
|
FDA asks AndroGel, Testim producers to include boxed warning
The US Food and Drug Administration (FDA) asked manufacturers of two prescription topical testosterone gel products, AndroGel 1% and Testim 1%, to include a boxed warning on the products' labels.The agency is requiring this action...
|
|
|
Zacks Analyst Blog Highlights: Auxilium Pharmaceuticals, Inc., Pfizer, Cognizant Technology Solutions Corp., N
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog.Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently...
|
|
|
MedWatch - Testosterone gel products: Boxed warning required to inform users of risk of unintended secondary e
Testosterone gel products (AndroGel 1% and Testim 1%) ROCKVILLE, Md., May 7, 2009--Audience: Urological and Endocrinological healthcare professionals, pediatricians FDA notified healthcare professionals that it will require two...
|
|
|
CPEX Pharmaceuticals Reports First-Quarter 2009 Financial Results
CPEX began operating as an independent publicly traded company after its spin-off from Bentley Pharmaceuticals, Inc.on June 30, 2008 (the Separation Date). The financial results reported for the three months ended March 31, 2008 (before...
|
|
|
CPEX Pharmaceuticals Reports First-Quarter 2009 Financial Results
EXETER, N.H.--(BUSINESS WIRE)-- (NASDAQ: CPEX - News) today reported its financial results for the first quarter ended March 31, 2009.For the quarter the Company reported revenues of $4.0 million and a net loss of $468,000. CPEX began...
|
